49 related articles for article (PubMed ID: 10194076)
1. Influenza Vaccination Can Broadly Activate the HIV Reservoir During Antiretroviral Therapy.
Christensen-Quick A; Chaillon A; Yek C; Zanini F; Jordan P; Ignacio C; Caballero G; Gianella S; Smith D
J Acquir Immune Defic Syndr; 2018 Nov; 79(3):e104-e107. PubMed ID: 30085954
[No Abstract] [Full Text] [Related]
2. Adult Influenza Vaccination - Seizing Every Opportunity.
Wiley Z; Roque Gardner A
NEJM Evid; 2024 Apr; 3(4):EVIDe2400032. PubMed ID: 38805613
[No Abstract] [Full Text] [Related]
3. Response to BNT162b2 mRNA COVID-19 vaccine of ART-experienced people living with HIV: a prospective analysis from a single-center study in Rome, Italy.
Lombardi F; Belmonti S; Di Giambendetto S
Infez Med; 2023; 31(3):359-363. PubMed ID: 37701380
[TBL] [Abstract][Full Text] [Related]
4. Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller woman.
Di Girolamo L; Ferrara M; Trevisan G; Longo BM; Allice T; Burdino E; Alladio F; Fantino S; Di Perri G; Calcagno A; Bonora S
Virol J; 2023 Jun; 20(1):123. PubMed ID: 37312093
[TBL] [Abstract][Full Text] [Related]
5. Standard vaccines increase HIV-1 transcription during antiretroviral therapy.
Yek C; Gianella S; Plana M; Castro P; Scheffler K; García F; Massanella M; Smith DM
AIDS; 2016 Sep; 30(15):2289-98. PubMed ID: 27427877
[TBL] [Abstract][Full Text] [Related]
6. Influenza vaccination in HIV-positive subjects: latest evidence and future perspective.
Ceravolo A; Orsi A; Parodi V; Ansaldi F
J Prev Med Hyg; 2013 Mar; 54(1):1-10. PubMed ID: 24396998
[TBL] [Abstract][Full Text] [Related]
7. Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults.
Ansaldi F; Valle L; de Florentiis D; Parodi V; Murdaca G; Bruzzone B; Durando P; Setti M; Icardi G
Hum Vaccin Immunother; 2012 Aug; 8(8):1048-52. PubMed ID: 22832261
[TBL] [Abstract][Full Text] [Related]
8. Effect of treating co-infections on HIV-1 viral load: a systematic review.
Modjarrad K; Vermund SH
Lancet Infect Dis; 2010 Jul; 10(7):455-63. PubMed ID: 20610327
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults.
Durando P; Fenoglio D; Boschini A; Ansaldi F; Icardi G; Sticchi L; Renzoni A; Fabbri P; Ferrera A; Parodi A; Bruzzone B; Gabutti G; Podda A; Del Giudice G; Fragapane E; Indiveri F; Crovari P; Gasparini R
Clin Vaccine Immunol; 2008 Feb; 15(2):253-9. PubMed ID: 18003811
[TBL] [Abstract][Full Text] [Related]
10. Preparation of the HIV-infected Traveler to the Tropics.
Karp CL
Curr Infect Dis Rep; 2001 Feb; 3(1):50-58. PubMed ID: 11177731
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults.
King JC; Treanor J; Fast PE; Wolff M; Yan L; Iacuzio D; Readmond B; O'Brien D; Mallon K; Highsmith WE; Lambert JS; Belshe RB
J Infect Dis; 2000 Feb; 181(2):725-8. PubMed ID: 10669363
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and protective efficacy of influenza vaccination.
Hannoun C; Megas F; Piercy J
Virus Res; 2004 Jul; 103(1-2):133-8. PubMed ID: 15163501
[No Abstract] [Full Text] [Related]
13. Vaccine-preventable influenza disease burden from clinical trials of Vaxigrip - an inactivated split virion influenza vaccine - supports wider vaccine use.
Arnoux S; Weinberger C; Gessner BD
Vaccine; 2007 Nov; 25(45):7720-31. PubMed ID: 17920168
[TBL] [Abstract][Full Text] [Related]
14. Influenza, influenza virus vaccine, and human immunodeficiency virus infection.
Couch RB
Clin Infect Dis; 1999 Mar; 28(3):548-51. PubMed ID: 10194076
[No Abstract] [Full Text] [Related]
15. Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response.
Fuller JD; Craven DE; Steger KA; Cox N; Heeren TC; Chernoff D
Clin Infect Dis; 1999 Mar; 28(3):541-7. PubMed ID: 10194075
[TBL] [Abstract][Full Text] [Related]
16. Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy.
Günthard HF; Wong JK; Spina CA; Ignacio C; Kwok S; Christopherson C; Hwang J; Haubrich R; Havlir D; Richman DD
J Infect Dis; 2000 Feb; 181(2):522-31. PubMed ID: 10669335
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
